Literature DB >> 30809685

Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.

Judith Lammer1, Rüdiger Hein, Sophie Roenneberg, Tilo Biedermann, Thomas Volz.   

Abstract

Linear IgA bullous dermatosis (LABD) is a rare subepidermal autoimmune blistering disease characterized by linear deposition of IgA along the basement membrane zone. Although most reported cases are idiopathic, there is a subset of patients with drug-induced LABD. Various drugs have been associated with the drug-induced form of the disease. This paper reviews the literature on drugs reported to elicit linear IgA dermatosis and its specific clinical presentation. In addition, a case report of a 77-year-old male patient with linear IgA dermatosis induced by vancomycin is described. The aim of this paper is to emphasize the need to include this differential diagnosis in cases of suspected adverse drug reactions, as well as to highlight the role of drugs in LABD.

Entities:  

Keywords:  autoimmunity; drug-induced linear IgA bullous dermatosis; vancomycin

Mesh:

Substances:

Year:  2019        PMID: 30809685     DOI: 10.2340/00015555-3154

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Vancomycin-induced linear IgA bullous dermatosis.

Authors:  Claire J Wiggins; Susan Y Chon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-26

2.  A 62-year-old man with new-onset bullae.

Authors:  August J Generoso; Jordana A Goldman; Alan H Wolff
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

Review 3.  Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.

Authors:  Linda J Zhu; Anne Y Liu; Priscilla H Wong; Anna Chen Arroyo
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-29       Impact factor: 10.817

4.  Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine.

Authors:  F Hali; A Kerouach; H Alatawna; S Chiheb; H Lakhdar
Journal:  Clin Exp Dermatol       Date:  2021-12-08       Impact factor: 4.481

5.  Localized Blistering Eruption of the Face and Neck - A Case Study and Differential Considerations.

Authors:  Małgorzata Michalska-Jakubus; Anita Wdowiak-Filip; Cezary Kowalewski; Katarzyna Woźniak; Dorota Krasowska
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-19

Review 6.  Immunoglobulin Disorders and the Oral Cavity: A Narrative Review.

Authors:  Maja Ptasiewicz; Dominika Bębnowska; Paulina Małkowska; Olga Sierawska; Agata Poniewierska-Baran; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska; Renata Chałas
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

7.  Linear IgA bullous dermatosis with Koebner phenomenon in a liver transplant patient.

Authors:  Bartosz Ptak; Emilia Knosala; Grażyna Wąsik; Rafał Białynicki-Birula; Wojciech Baran; Aleksandra Batycka-Baran
Journal:  Postepy Dermatol Alergol       Date:  2022-07-14       Impact factor: 1.664

Review 8.  Linear Immunoglobulin a Bullous Dermatosis in Children.

Authors:  Francesca Mori; Francesca Saretta; Lucia Liotti; Mattia Giovannini; Riccardo Castagnoli; Stefania Arasi; Simona Barni; Carla Mastrorilli; Luca Pecoraro; Lucia Caminiti; Gian Luigi Marseglia; Annick Barbaud; Elio Novembre
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

9.  Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.

Authors:  William J Nahm; Michelle Juarez; Julie Wu; Randie H Kim
Journal:  J Cutan Pathol       Date:  2022-08-03       Impact factor: 1.458

Review 10.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.